Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block for Congenital Hip Dislocation Surgery
NCT04212039Completed
- Sponsor
- Atatürk University
- Start
- Jan 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Atatürk University. Primary endpoint: Face, Legs, Activity, Cry and Consolability Score at 24 hours. Started Jan 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04212039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04212039.